Tech Company Inital Public Offerings
Kite Pharma IPO
Kite Pharma was purchased by . Shares were listed on 6/19/2014.
Transaction Overview
Company Name
Announced On
6/19/2014
Transaction Type
IPO
Amount
$127,500,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2400 Bdwy.
Santa Monica, CA 90404
USA
Santa Monica, CA 90404
USA
Phone
Website
Email Address
Overview
Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arie Belldegrun
Chief Financial Officer
Cynthia Buttita
Chief Scientific Officer
Margo Roberts
VP - Bus. Development
Helen Kim
VP - R & D
David Chang
Browse more venture capital transactions:
Prev: 6/19/2014: Puppet venture capital transaction
Next: 6/19/2014: ForgeRock venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs